These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9274430)

  • 1. Radiotherapy-induced second cancers: are we doing enough to protect young patients?
    Epstein R; Hanham I; Dale R
    Eur J Cancer; 1997 Apr; 33(4):526-30. PubMed ID: 9274430
    [No Abstract]   [Full Text] [Related]  

  • 2. In regards to Hall: intensity-modulated radiation therapy, protons, and the risk of second cancers (Int J Radiat Oncol Biol Phys 2006;65:1-7).
    Macklis R
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1593-4; author reply 1595. PubMed ID: 17126216
    [No Abstract]   [Full Text] [Related]  

  • 3. Active minimisation of radiation scatter during breast radiotherapy: management implications for young patients with good-prognosis primary neoplasms.
    Epstein RJ; Kelly SA; Cook M; Bateman A; Paddick I; Kam KC; Dunn P; Hanham IW; Dale RG; Price PM
    Radiother Oncol; 1996 Jul; 40(1):69-74. PubMed ID: 8844891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective.
    Shapiro CL; Mauch PM
    J Clin Oncol; 1992 Nov; 10(11):1662-5. PubMed ID: 1403048
    [No Abstract]   [Full Text] [Related]  

  • 5. [Breast cancer after radiotherapy: Risk factors and suggestion for breast delineation as an organ at risk in the prepuberal girl].
    Demoor-Goldschmidt C; Supiot S; Mahé MA
    Cancer Radiother; 2012 Apr; 16(2):140-51. PubMed ID: 22342367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review.
    Tubiana M
    Radiother Oncol; 2009 Apr; 91(1):4-15; discussion 1-3. PubMed ID: 19201045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of radio-induced cancers].
    Cosset JM; Chargari C; Demoor C; Giraud P; Helfre S; Mornex F; Mazal A
    Cancer Radiother; 2016 Sep; 20 Suppl():S61-8. PubMed ID: 27523416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
    Hall EJ
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing second breast cancers: a potential role for prophylactic mammary irradiation.
    Brenner DJ; Shuryak I; Russo S; Sachs RK
    J Clin Oncol; 2007 Nov; 25(31):4868-72. PubMed ID: 17971581
    [No Abstract]   [Full Text] [Related]  

  • 10. Creating the basis for a breast health program for female survivors of Hodgkin disease using a participatory research approach.
    Crom DB; Hinds PS; Gattuso JS; Tyc V; Hudson MM
    Oncol Nurs Forum; 2005 Nov; 32(6):1131-41. PubMed ID: 16270109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose to contralateral breast--a comparative study.
    Brooks PS
    Med Dosim; 1995; 20(4):301-7. PubMed ID: 8703328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-rate effects when estimating risks for second malignancies: in regard to Fontenot et al (Int J Radiat Oncol Biol Phys 2009;74:616-622).
    Paganetti H; Athar BS; Bednarz B
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1624; author reply 1624-5. PubMed ID: 19931743
    [No Abstract]   [Full Text] [Related]  

  • 13. Updated relevance of mammographic screening modalities in women previously treated with chest irradiation for Hodgkin disease.
    Colin C; de Vathaire F; Noël A; Charlot M; Devic C; Foray N; Valette PJ
    Radiology; 2012 Dec; 265(3):669-76. PubMed ID: 23175541
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies.
    Overholser L; Shagisultanova E; Rabinovitch RA; Kounalakis N; Diamond J; Finlayson CA; Fisher CM; Kabos P; Elias AD; Borges VF; Mayordomo J
    Oncology (Williston Park); 2016 Dec; 30(12):1063-70. PubMed ID: 27987198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
    Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing scatter radiation to the contralateral breast with a mobile, conformal shield during breast cancer radiotherapy.
    Macklis RM; Crownover RL; Crowe J; Willoughby T; Sohn J
    Am J Clin Oncol; 1999 Aug; 22(4):419-25. PubMed ID: 10440204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncomplicated and Cancer-Free Control Probability (UCFCP): A new integral approach to treatment plan optimization in photon radiation therapy.
    Sánchez-Nieto B; Romero-Expósito M; Terrón JA; Sánchez-Doblado F
    Phys Med; 2017 Oct; 42():277-284. PubMed ID: 28392313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
    Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Mâsse B; Vigneault E; Vass S; del Vecchio P; Roy J
    J Natl Cancer Inst; 2005 Apr; 97(7):481-8. PubMed ID: 15812073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protraction of dose effects for radiogenic breast cancer.
    Rossi HH
    Radiat Res; 1999 Jul; 152(1):104-5. PubMed ID: 10428682
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiation exposure and relative risk of breast cancer: an error perpetuated.
    Cox CW
    Radiology; 2012 Jan; 262(1):369-70. PubMed ID: 22190663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.